Kelly Crowe

Medical science

Kelly Crowe is a medical sciences correspondent for CBC News, specializing in health and biomedical research. She joined CBC in 1991, and has spent 25 years reporting on a wide range of national news and current affairs, with a particular interest in science and medicine.

Latest from Kelly Crowe

Medical journal report that a woman without symptoms spread the coronavirus in Germany was wrong

Research is messy and sometimes it's wrong. But science is also self-correcting. That's what happened after a report in the New England Journal of Medicine mistakenly concluded that a woman from Shanghai had spread the coronavirus to colleagues in Germany before experiencing symptoms herself.
Second Opinion

'We're opening everything': Scientists share coronavirus data in unprecedented way to contain, treat disease

Normally, science is highly competitive and secretive, with universities and private sector companies patenting knowledge, scientific journals putting research behind paywalls and all research peer-reviewed before the data is released. But for the moment those barriers have fallen as scientists share research and work together to battle this coronavirus epidemic.

Bats and sneezing camels: A tale of two viruses

Will the new coronavirus follow the path of SARS and disappear? Or will it be more like MERS and become a persistent threat?

Canada's Ebola vaccine almost didn't happen, new study reveals

Dalhousie University professor Matthew Herder accessed hundreds of government documents to find out what really happened as Canadian scientists tried for years to get the pharmaceutical industry interested in their discovery of an Ebola vaccine.

Why we put climate concerns on hold for the holiday season

The mix of tradition, culture and ‘Christmas marketing creep’ can defeat our low-waste low-carbon intentions.

Why Big Oil faces court cases that echo the litigation against Big Tobacco in the '90s

How much did the oil industry know about the impact of fossil fuel emissions on the climate? When did they know it? And what did they do with that knowledge? Those are the central questions in a series of court cases attempting to hold companies accountable for their role in climate change.

Canadian breakthrough that became the world's most expensive drug, then vanished, gets second chance

Glybera, a made-in-Canada medical breakthrough that became known as the world's most expensive drug, was abandoned after only one commercial sale in Europe. After seeing a CBC report on Glybera's fate, Canada's National Research Council decided to develop an affordable version for Canadians.

How 'organized climate change denial' shapes public opinion on global warming

As citizens around the world demand climate action, it might seem that climate skepticism has disappeared. But researchers say it has taken a new form, Kelly Crowe writes.
Second Opinion

A team of maverick scientists is trying to build a bootleg version of a million-dollar drug

Glybera was a made-in-Canada medical breakthrough that became the world’s most expensive drug and then quickly disappeared from the market because no one could afford the $1-million price for a dose. Now, a group of maverick biohackers is attempting to build an affordable bootleg version.
Second Opinion

Solving the mystery of the weight-loss plateau

Why the body’s calorie-burning capacity drops has so far not been explained. There are theories that something puts the brakes on the body’s ability to turn up its fat-burning machinery and a new paper describes one possible system.
Second Opinion

Are food politics defeating Canada's healthy eating strategy?

With the clock ticking toward a federal election, time is running out for the Trudeau government's signature healthy eating strategy. The law banning the advertisement of junk food to kids died in the Senate last month. Advocates are now worried that new front-of-package food labelling rules won't happen.
Second Opinion

Listeria risk from recalled packaged kale highlights pathogen's challenge

This is the third time in eight months that an Eat Smart product has been recalled in Canada because of Listeria, one of the most dangerous foodborne pathogens.
Second Opinion

A stem cell 'cautionary tale' as Health Canada cracks down on private clinics

Canada's stem cell controversy heated up this week as Health Canada ordered private clinics to stop so-called "stem cell" treatments. At the same time, a St. John's radiologist published a gruesome story about a stem cell treatment that went terribly wrong.
Second Opinion

Mice are not people: Fighting spin in medical science

When it comes to health and science research, spin exaggerates the benefit of a treatment and plays down the risks. And spin can affect how people judge the benefit of treatments they read about in the news, according to the first randomized controlled trial to test the effect of spin on readers.
Second Opinion

Why did deer meat from an infected herd end up in Canada's food chain?

Scientists still don't know whether chronic wasting disease is a human health risk. But there is emerging evidence by Canadian researchers that this deadly animal disease could jump the species barrier. That's why some scientists are calling on Ottawa to take greater precautions.